Comparison of Biliary Drainage Techniques for MBO: A Meta-Analysis

Area of Science:

• Gastroenterology
• Interventional Radiology
• Oncology

Background:

• Malignant biliary obstruction (MBO) significantly affects patient well-being and quality of life.
• Percutaneous transhepatic biliary drainage (PTBD) and endoscopic biliary drainage (EBD) are primary interventions for MBO.
• Comparative effectiveness of PTBD versus EBD for MBO remains inadequately defined.

Purpose of the Study:

• To systematically compare the efficacy and safety of EBD and PTBD in managing MBO.
• To evaluate key outcomes including technical success, complication rates, and patient recovery metrics.

Main Methods:

• A systematic literature review of case-control studies published from January 2010 to present.
• Analysis of five studies involving 721 patients comparing PTBD and EBD.
• Statistical analysis of outcomes such as technical success, complications, pancreatitis, bleeding, hospital stay, and metastasis rates.

Main Results:

• No significant differences were observed in major complications, bleeding, hospital stay duration, or metastasis rates between PTBD and EBD.
• PTBD demonstrated a statistically significant reduction in overall complications and post-procedure pancreatitis compared to EBD.
• These findings suggest a potential benefit of PTBD in mitigating specific adverse events.

Conclusions:

• PTBD may present advantages over EBD for MBO management, characterized by a lower incidence of complications and pancreatitis.
• PTBD is suggested as a potentially safer and more effective treatment option for malignant biliary obstruction.
• High-quality, large-scale clinical trials are warranted to substantiate these preliminary findings and solidify PTBD's role.